[-empyre-] Synthusiasts
- To: soft_skinned_space <empyre@lists.cofa.unsw.edu.au>
- Subject: [-empyre-] Synthusiasts
- From: Ryan Griffis <ryan.griffis@gmail.com>
- Date: Wed, 17 Oct 2007 17:40:03 -0500
- Delivered-to: empyre@gamera.cofa.unsw.edu.au
- Dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=gmail.com; s=beta; h=domainkey-signature:received:received:mime-version:references:content-type:message-id:content-transfer-encoding:from:subject:date:to:x-mailer; bh=uBQ+nuW+d2/GTvTB3Y4Xyci+Wr/smxB5LnxDsdhZOpU=; b=FGRM2n3UjZOCRHzJn3w2C1m6Fkex84eVsNz4SEfwfP9VVsPFUZiCfX+BpE7HnEXrauyeZMSFv2RqplgO0bqs3FXqsW5VpaROVuVTn8L/FKh+iMGLS63UnsfwIHpA+SxLZqVekXwer9j8gPnKV3pCtWFtUlnOUxq1V5m7U/qv1oo=
- Domainkey-signature: a=rsa-sha1; c=nofws; d=gmail.com; s=beta; h=received:mime-version:references:content-type:message-id:content-transfer-encoding:from:subject:date:to:x-mailer; b=DjYs7uoFqlftv+yORluLtNjjxFo8QxUqJMq3CJbLVgM2XoVFuPuDJqNSSyDrX1YqCN5H2eABZ9o6yGQWTvZz3YRV7qi3Euoxr8kw9OxL1Z69US1xMA/X5txwWLM/QNkh9LIoToKwVAe6ohL4hYpxqNqqP5DmWq5Y9qiHFUW0EdM=
- References: <FB866F6C-9A25-4EAF-A829-43A6A26CCD80@etcgroup.org>
- Reply-to: soft_skinned_space <empyre@lists.cofa.unsw.edu.au>
“This report is a partial consideration of governance by a partisan
group of authors,” explains Jim Thomas of ETC Group. “Its authors are
‘Synthusiasts’ – or, unabashed synthetic biology boosters – who are
primarily concerned about holding down costs and regulatory burdens
that could allegedly stymie the rapid development of the new
industry. By focusing narrowly on safety and security in a U.S.-
centric context, the report conveniently overlooks important
questions related to power, control and the economic impacts of
synthetic biology. The authors have ignored the first and most basic
questions: Is synthetic biology socially acceptable or desirable? Who
should decide? Who will control the technology, and what are its
potential impacts?”
Begin forwarded message:
Syns of Omission:
Civil Society Organizations Respond to Report on Synthetic Biology
Governance from the J. Craig Venter Institute and Alfred P. Sloan
Foundation
A report released today on policy options for governance of
synthetic biology is a disappointing effort that fails to address
wider societal concerns about the rapid deployment of a powerful
and controversial new technology. Synthetic biology aims to
commercialize new biological parts, devices and living organisms
that are constructed from synthetic DNA – including dangerous
pathogens. Synthetic biologists are attempting to harness cells as
tiny factories for industrial production of chemicals, including
pharmaceuticals and fuels. ETC Group describes the synthetic
biology approach as “extreme genetic engineering.”
The report, authored by scientists and employees from the J. Craig
Venter Institute, Massachusetts Institute of Technology (MIT) and
the Center for Strategic & International Studies (Washington, D.C.)
was funded by a half-million dollar grant from the U.S.-based
Alfred P. Sloan Foundation and billed as a “project to examine the
societal implications of synthetic genomics.” The study was more
than two years in the making, but the report makes no policy
recommendations and failed to properly consult civil society. While
the authors do acknowledge possible bio-error (i.e., synbio
accidents that cause unintended harm to human health and the
environment), the emphasis is on how to impede bioterrorists “in a
post-September 11 world.”
“This report is a partial consideration of governance by a partisan
group of authors,” explains Jim Thomas of ETC Group. “Its authors
are ‘Synthusiasts’ – or, unabashed synthetic biology boosters – who
are primarily concerned about holding down costs and regulatory
burdens that could allegedly stymie the rapid development of the
new industry. By focusing narrowly on safety and security in a U.S.-
centric context, the report conveniently overlooks important
questions related to power, control and the economic impacts of
synthetic biology. The authors have ignored the first and most
basic questions: Is synthetic biology socially acceptable or
desirable? Who should decide? Who will control the technology, and
what are its potential impacts?”
The report’s authors include representatives from institutions that
have a vested interest in commercialization of synthetic biology.
According to the J. Craig Venter Institute, one of the three
institutions that led the study, scientists are just weeks or
months away from announcing the creation of the world’s first-ever
living bacterium with entirely synthetic DNA and a novel genome.
Scientists from the Venter Institute have already applied for
patents on the artificial microbe, and Craig Venter predicts that
it could be the first billion or trillion dollar organism. The
report fails to address issues of ownership, monopoly practices or
intellectual property claims arising from synthetic biology.
“The sixty-page report has oodles of input from a small circle of
scientists and policy ‘experts,’ but the 20-month long study fails
to incorporate views of civil society and social movements,” points
out Hope Shand, ETC Group’s Research Director. “An insular process
like the one that produced the Sloan report instills little
confidence in the results.”
The economic and technical barriers to synthetic genomics are
collapsing. Using a laptop computer, published gene sequence
information and mail-order synthetic DNA, it is becoming routine to
construct genes or entire genomes from scratch – including those of
lethal pathogens. The tools for DNA synthesis technologies are
advancing at break-neck pace – they’re becoming cheaper, faster and
widely accessible. The authors acknowledge this reality, and
evaluate several options for addressing it.
One proposal aimed at “legitimate users” of the technology – those
working in industry labs, for example – is to broaden the
responsibilities of Institutional Biosafety Committees, which were
established (in the US) to assess the biosafety and environmental
risks of proposed recombinant DNA experiments.
Edward Hammond, Director of the Sunshine Project, a biotech and
bioweapons watchdog, argues, “Institutional Biosafety Committees
are a documented disaster. IBCs aren’t up to their existing task of
overseeing genetic engineering research, much less ready to absorb
new synthetic biology and security mandates. The authors of this
report are aware of the abject failure of voluntary compliance by
IBCs, including by the Venter Institute’s own IBC. So it is very
difficult to interpret their suggestion that IBCs oversee synthetic
biology as anything but a cynical attempt to avoid effective
governance.”
Options for governing synthetic biology must not be set by the
synthetic biologists themselves – broad societal debate on synbio’s
wider implications must come first. Synthetic microbes should be
treated as dangerous until proven harmless and strong democratic
oversight should be mandatory – not optional. Earlier this year the
ETC Group recommended a ban on environmental release of de novo
synthetic organisms until wide societal debate and strong
governance are in place.
ETC and other civil society organizations have called repeatedly
for an inclusive, wide ranging public dialogue process on societal
implications and oversight options for Synthetic Biology.
The full text of “Synthetic Genomics: Options for Governance” is
available here: http://www.jcvi.org/
ETC Group’s January 2007 report on synthetic biology, Extreme
Genetic Engineering, is available here: http://www.etcgroup.org/en/
materials/publications.html?pub_id=602
Backgrounder: Open Letter on Synthetic Biology from Civil Society,
May 2006:
http://www.etcgroup.org/en/materials/publications.html?pub_id=11
This archive was generated by a fusion of
Pipermail 0.09 (Mailman edition) and
MHonArc 2.6.8.